<div id="readability-page-1">04:41 PM EST, 12/04/2025 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said late Thursday it has launched a proposed underwritten public offering of its common stock.The company said underwriters will have a 30-day option to buy up to 15% additional shares. Terms and size of the offering remain subject to market conditions.Capricor said proceeds will support the development and manufacturing of its product candidates, as well as general corporate purposes.Shares of the company were up 2.6% in after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Capricor治疗

东部标准时间 2025 年 12 月 4 日下午 4:41（MT Newswires）-- Capricor Therapeutics（CAPR）周四晚间表示，已启动一项拟议的承销公开发行普通股。该公司表示，承销商将有 30 天的选择权，可以购买最多 15% 的额外股份。发行的条款和规模仍然取决于市场条件。Capricor 表示，所得款项将用于支持其产品候选的开发和生产，以及一般企业用途。该公司的股票在盘后交易中上涨了 2.6%。MT Newswires 不提供投资建议。未经授权的复制是严格禁止的

Capricor 治疗公司启动了拟议的公开股票发行